Chromosome Aberrations

The grounding supports chromosomal abnormalities in the embryo as a cause in miscarriage, and it also notes that large genomic alterations can arise through mutational processes in developing tumors. These alterations include copy number gains and losses, chromosome shattering and reassembly, chromothripsis, chromoplexy, and extrachromosomal DNA formation. No broader aetiology is supported by the supplied material.

The biological effect of chromosome aberrations is disruption of genomic structure or dosage, which can alter the expression of many genes. In cancer, large genomic rearrangements can substantially affect cell fitness and tumor development and evolution. The grounding also indicates that genetic features can be defining criteria for some hematologic neoplasms, but it does not provide a more specific mechanism for chromosome aberrations as a disease category.

The supplied grounding supports embryonic chromosomal abnormalities as a factor associated with miscarriage. It also mentions maternal endocrine abnormalities, organ malformations, abnormal immune factors, and cervical insufficiency as causes of miscarriage, but it does not establish these as risk factors for chromosome aberrations themselves. No additional risk factors are supported.

The grounding does not support a disease-specific standard of care for chromosome aberrations. It only notes that miscarriage treatment may include hormonal and immunological drugs and surgery depending on aetiology, but this is not presented as treatment for chromosome aberrations specifically. No modality- or drug-class-level standard treatment can be stated from the supplied material.